~~PART I~~	~~FINANCIAL INFORMATION~~
PART I			FINANCIAL INFORMATION
~~Item 1.~~			~~Financial Statements~~		1
Item 1.			Financial Statements		1
			Condensed Consolidated Balance Sheets		1

	Condensed Consolidated Statements of Operations	2

	Condensed Consolidated Statements of Stockholders’ Equity (Deficit)	3

	Condensed Consolidated Statements of Cash Flows	5

	Notes to Condensed Consolidated Financial Statements	6

Item 2.			Management’s Discussion and Analysis of Financial Condition and Results of Operations		13 15

Item 3.	Quantitative and Qualitative Disclosures About Market Risk			19 21

Item 4.	Controls and Procedures			19 21

PART II			OTHER INFORMATION		23

Item 1.			Legal Proceedings		20 23
Item 1A.			Risk Factors		23
~~Item 1A.~~			~~Risk Factors~~	20

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds			20 23

Item 3.	Defaults Upon Senior Securities			20 24

Item 4.	Mine Safety Disclosures			20 24
Item 5.			Other Information		24
Item 5.6.			~~Other Information~~ Exhibits		20 25
			SIGNATURES
~~Item 6.~~	~~Exhibits~~	21

	~~SIGNATURES~~	22 26

Forward-Looking Statements

The discussions in this Quarterly Report contain forward-looking statements reflecting our current expectations that involve risks and uncertainties. When used in this Report, the words “anticipate”, expect”, “plan”, “believe”, “seek”, “estimate” and similar expressions are intended to identify forward-looking statements. These are statements that relate to future periods and include, but are not limited to, statements about the features, benefits and performance of our products, our ability to introduce new product offerings and increase revenue from existing products, expected expenses including those related to selling and marketing, product development and general and administrative, our beliefs regarding the health and growth of the market for our products, anticipated increase in our customer base, expansion of our products functionalities, expected revenue levels and sources of revenue, expected impact, if any, of legal proceedings, the adequacy of liquidity and capital resource, and expected growth in business. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks and uncertainties include, but are not limited to, market acceptance for our products, our ability to attract and retain customers for existing and new products, our ability to control our expenses, our ability to recruit and retain employees, legislation and government regulation, shifts in technology, global and local business conditions, our ability to effectively maintain and update our product and service portfolio, the strength of competitive offerings, the prices being charged by those competitors and the risks discussed elsewhere herein. These forward-looking statements speak only as of the date hereof. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

All references in this Form 10-Q that refer to the “Company”, “Workhorse Group”, “Workhorse”, “we,” “us” or “our” are to Workhorse Group Inc. ~~and unless otherwise differentiated, its wholly-owned subsidiaries, Workhorse Technologies Inc., Workhorse Motor Works Inc. and Workhorse Properties Inc.~~

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Workhorse Group Inc.

Condensed Consolidated Balance Sheets

~~June~~

September 30, 2019 (Unaudited) and December 31, 2018

June 30,
2019 December 31,
2018
Assets

Current assets:
Cash and cash equivalents $ 23,519,496 $ 1,512,750
Lease receivable 42,244 48,271
Inventory 2,197,683 2,533,616
Prepaid expenses and deposits 1,720,319 2,274,595
27,479,742 6,369,232

Noncurrent assets:
Property, plant and equipment, net of accumulated depreciation of $2,601,263 and $2,407,477 at June 30, 2019 and December 31, 2018 8,009,037 5,237,451
Lease receivable 179,982 198,090
$ 35,668,761 $ 11,804,773

Liabilities and Stockholders’ Equity (Deficit)

Current liabilities:
Accounts payable $ 2,010,334 $ 4,340,463
Accrued liabilities 4,047,550 3,946,386
Warranty liability 6,573,560 7,058,769
Warrant liability 33,529,599 1,822,819
Customer deposits 359,000 406,000
Duke financing obligation 1,340,700 1,340,700
Revolving loan 5,854,140 -
53,714,883 18,915,137

Long-term debt 8,572,182 8,312,079
Mandatory redeemable series B preferred stock 18,409,510 -
Commitments and Contingencies
Stockholders’ equity (deficit):
Series A preferred stock, par value of $.001 per share 75,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2019 and December 31, 2018 - -
Common stock, par value of $.001 per share 250,000,000 shares authorized, 66,081,812 shares issued and outstanding at June 30, 2019 and 58,270,934 shares issued and outstanding at December 31, 2018 66,082 58,271
Additional paid-in capital 139,670,292 126,076,782
Accumulated deficit (184,764,188 ) (141,557,496 )
(45,027,814 ) (15,422,443 )
$ 35,668,761 $ 11,804,773


	September 30, 2019		December 31, 2018
Assets
Current assets:
Cash and cash equivalents	$	9,261,151	$	1,512,750
Restricted cash	900,000		—
Lease receivable	42,860		48,271
Inventory, net	2,388,988		2,533,616
Prepaid expenses and deposits	6,355,690		2,274,595
Total current assets	18,948,689		6,369,232

Property, plant and equipment, net of accumulated depreciation of $2,588,647 and $2,407,477 at September 30, 2019 and December 31, 2018	8,923,635		5,237,451
Lease receivable	169,638		198,090
Total Assets	$	28,041,962	$	11,804,773

Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Accounts payable	$	995,510	$	4,340,463
Accrued liabilities	3,996,365		3,946,386
Warranty liability	6,506,971		7,058,769
Warrant liability	19,901,139		1,822,819
Customer deposits	334,000		406,000
Duke financing obligation	1,340,700		1,340,700
Current portion of long-term debt	6,354,140		—
Total current liabilities	39,428,825		18,915,137

Long-term debt	8,205,270		8,312,079
Mandatory redeemable series B preferred stock	18,772,628		—
Commitments and contingencies
Stockholders’ equity (deficit):
Series A preferred stock, par value $0.001 per share, 75,000,000 shares authorized, 0 shares issued and outstanding at September 30, 2019 and December 31, 2018	—		—
Common stock, par value $0.001 per share,,250,000,000 shares authorized, 66,189,613 shares issued and outstanding at September 30, 2019 and 58,270,934 at December 31, 2018	66,190		58,271
Additional paid-in capital	141,030,711		126,076,782
Accumulated deficit	(179,461,662)		(141,557,496)
Total stockholders' equity (deficit)	(38,364,761)		(15,422,443)
Total Liabilities and Stockholders' Equity (Deficit)	$	28,041,962	$	11,804,773

See accompanying notes to condensed consolidated financial statements.

Workhorse Group Inc.

Condensed Consolidated Statements of Operations

For the Three and ~~Six~~Nine Months Ended ~~June~~September 30, 2019 and 2018

(Unaudited)

Three Months Ended
June 30, Six Months Ended
June 30,
2019 2018 2019 2018

Net sales $ 5,508 $ 170,684 $ 369,690 $ 730,913
Cost of sales 930,164 1,655,905 2,327,770 3,370,275
Gross loss (924,656 ) (1,485,221 ) (1,958,080 ) (2,639,362 )

Operating expenses
Selling, general and administrative 1,996,054 3,003,202 4,086,944 5,403,349
Research and development 1,216,727 1,894,712 2,579,002 4,232,343
Total operating expenses 3,212,781 4,897,914 6,665,946 9,635,692

Interest expense, net 32,718,876 526,162 34,496,459 1,052,049

Net loss (36,856,313 ) (6,909,297 ) (43,120,485 ) (13,327,103 )

Deemed dividends 86,207 765,179 86,207 765,179

Net loss attributable to common stockholders $ (36,942,520 ) $ (7,674,476 ) $ (43,206,692 ) $ (14,092,282 )

Net loss attributable to common stockholders per share - basic and diluted $ (0.61 ) $ (0.18 ) $ (0.71 ) $ (0.33 )

Weighted average number of common shares outstanding 60,530,168 42,406,471 60,530,168 42,406,471


	Three Months Ended September 30,						Nine Months Ended September 30,
	2019		2018		2019		2018
Net sales	$	4,258	$	10,997	$	373,948	$	741,910
Cost of sales	1,423,904		1,476,822		3,751,674		4,847,097
Gross loss	(1,419,646)		(1,465,825)		(3,377,726)		(4,105,187)

Operating expenses
Selling, general and administrative	2,551,406		3,363,103		6,638,350		8,766,452
Research and development	1,640,454		1,449,497		4,219,456		5,681,840
Total operating expenses	4,191,860		4,812,600		10,857,806		14,448,292

Loss from operations	(5,611,506)		(6,278,425)		(14,235,532)		(18,553,479)

Interest expense, net	5,882,081		(792,872)		23,582,427		259,177

Net loss	$	(11,493,587)	$	(5,485,553)	$	(37,817,959)	$	(18,812,656)

Net loss attributable to common stockholders per share - basic and diluted	$	(0.17)	$	(0.12)	$	(0.60)	$	(0.42)

Weighted average number of common shares outstanding	66,176,921		46,192,471		63,566,295		46,192,471

See accompanying notes to condensed consolidated financial statements.

Workhorse Group Inc.
Condensed Consolidated Statements of ~~Stockholders~~Stockholders’ Equity (Deficit)

(Unaudited)

Common Stock Series A
Preferred Stock Additional Total
Stockholders’
Number
of Shares Amount Number
of Shares Amount Paid-in
Capital Accumulated
Deficit Equity
(Deficit)
Balance, March 31, 2018 41,966,550 $ 41,966 $ - $ - $ 109,106,507 $ (110,707,807 ) $ (1,559,334 )
Issuance of common stock 3,034,169 1,065 - - 2,832,861 - 2,833,926
Stock options and warrants exercised 2,500 3 - - 2,748 - 2,751
Warrant exchange - 1,969 - - (1,969 ) - -
Deemed dividend, Sept 17 warrants - - - - 765,179 (765,179 ) -
Share based compensation - - - - 476,085 - 476,085
Net loss - - - - - (6,909,297 ) (6,909,297 )
Balance, June 30, 2018 45,003,219 $ 45,003 $ - $ - $ 113,181,411 $ (118,382,283 ) $ (5,155,869 )

Common Stock Series A
Preferred Stock Additional Total
Stockholders’
Number
of Shares Amount Number
of Shares Amount Paid-in
Capital Accumulated
Deficit Equity
(Deficit)
Balance, December 31, 2017 41,529,181 $ 41,529 $ - $ - $ 107,760,036 $ (104,290,001 ) $ 3,511,564
Issuance of common stock 3,429,395 1,460 - - 4,019,881 - 4,021,341
Stock options and warrants exercised 44,643 45 - - 90,021 - 90,066
Warrant exchange - 1,969 - - (1,969 ) - -
Deemed dividend, Sept 17 warrants - - - - 765,179 (765,179 ) -
Share based compensation - - - - 548,263 - 548,263
Net loss - - - - - (13,327,103 ) (13,327,103 )
Balance, June 30, 2018 45,003,219 $ 45,003 $ - $ - $ 113,181,411 $ (118,382,283 ) $ (5,155,869 )


	Common Stock				Series A Preferred Stock						Additional Paid-in Capital		Accumulated Deficit	Total Stockholders’ Equity (Deficit)
	Number of Shares	Amount		Number of Shares	Amount
Balance, June 30, 2018	45,003,219	$	45,003	—	$	—	$	113,181,411	$	(118,382,283)	$	(5,155,869)
Issuance of common stock	11,267,715	11,268		—	—		12,366,053		—		12,377,321



Stock-based compensation	—	—		—	—		254,963		—		254,963
Net loss	—	—		—	—		—		(5,485,553)		(5,485,553)
Balance, September 30, 2018	56,270,934	$	56,271	—	$	—	$	125,802,427	$	(123,867,836)	$	1,990,862

Common Stock Series A
Preferred Stock Additional
Paid-in
Capital Accumulated
Deficit Total
Stockholders’
Equity
(Deficit)
Number
of Shares Amount Number
of Shares Amount
Balance, December 31, 2017 41,529,181 $ 41,529 — $ — $ 107,760,036 $ (104,290,001) $ 3,511,564
Issuance of common stock 14,697,110 12,728 — — 16,385,934 — 16,398,662
Stock options and warrants exercised 44,643 45 — — 90,020 — 90,065
Warrant exchange — 1,969 — — (1,969) — —
Deemed dividend — — — — 765,179 (765,179) —
Stock-based compensation — — — — 803,227 — 803,227
Net loss — — — — — (18,812,656) (18,812,656)
Balance, September 30, 2018 56,270,934 $ 56,271 — $ — $ 125,802,427 $ (123,867,836) $ 1,990,862

Workhorse Group Inc.
Condensed Consolidated Statements of ~~Stockholders~~Stockholders’ Equity (Deficit) (Continued)

(Unaudited)

Common Stock Series A
Preferred Stock Additional Total
Stockholders’
Number
of Shares Amount Number
of Shares Amount Paid-in
Capital Accumulated
Deficit Equity
(Deficit)
Balance, March 31, 2019 61,496,990 $ 61,497 $ -   $ -   $ 129,764,361 $ (147,821,668 ) $ (17,995,810 )
Issuance of common stock 3,957,432 3,958 -   -   2,924,542 -   2,928,500
Stock options and warrants exercised 510,894 511 -   -   (511 ) -   -
Deemed dividend 116,496 116 86,091 (86,207 ) -
Share based compensation -   -   -   -   185,848 -   185,848
Value of warrants issued with preferred stock -   -   -   -   6,709,961 -   6,709,961
Net loss -   -   -   -   -   (36,856,313 ) (36,856,313 )
Balance, June 30, 2019 66,081,812 $ 66,082 $ -   $ -   $ 139,670,292 $ (184,764,188 ) $ (45,027,814 )

Common Stock Series A
Preferred Stock Additional Total
Stockholders’
Number
of Shares Amount Number
of Shares Amount Paid-in
Capital Accumulated
Deficit Equity
(Deficit)
Balance, December 31, 2018 58,270,934 $ 58,271 $ -   $ -   $ 126,076,782 $ (141,557,496 ) $ (15,422,443 )
Issuance of common stock 7,183,488 7,184 -   -   5,921,051 -   5,928,235
Stock options and warrants exercised 510,894 511 -   -   (511 ) -   -
Deemed dividend 116,496 116 86,091 (86,207 ) -
Share based compensation -   -   -   -   876,918 -   876,918
Value of warrants issued with preferred stock -   -   -   -   6,709,961 -   6,709,961
Net loss -   -   -   -   -   (43,120,485 ) (43,120,485 )
Balance, June 30, 2019 66,081,812 $ 66,082 $ -   $ -   $ 139,670,292 $ (184,764,188 ) $ (45,027,814 )


	Common Stock				Series A Preferred Stock						Additional Paid-in Capital		Accumulated Deficit	Total Stockholders’ Equity (Deficit)
	Number of Shares	Amount		Number of Shares	Amount
Balance, June 30, 2019	66,081,812	$	66,082	—	$	—	$	140,527,364	$	(167,968,075)	$	(27,374,629)

Stock options and warrants exercised	6,330	6		—	—		1,967		—		1,973

Stock-based compensation	—	—		—	—		334,711		—		334,711
Common stock issued for payment of Series B Preferred Stock dividend	101,471	102		—	—		166,669		—		166,771
Net loss	—	—		—	—		—		(11,493,587)		(11,493,587)
Balance, September 30, 2019	66,189,613	$	66,190	—	$	—	$	141,030,711	$	(179,461,662)	$	(38,364,761)


	Common Stock				Series A Preferred Stock						Additional Paid-in Capital		Accumulated Deficit	Total Stockholders’ Equity (Deficit)
	Number of Shares	Amount		Number of Shares	Amount
Balance,December 31, 2018	58,270,934	$	58,271	—	$	—	$	126,076,782	$	(141,557,496)	$	(15,422,443)
Issuance of common stock	7,183,488	7,184		—	—		5,921,051		—		5,928,235
Stock options and warrants exercised	517,224	517		—	—		1,456		—		1,973
Deemed dividend	116,496	116					86,091		(86,207)		—
Stock-based compensation	—	—		—	—		1,211,629		—		1,211,629
Effect of reclassification of warrants	—	—		—	—		857,072		—		857,072
Value of warrants issued with Series B Preferred Stock	—	—		—	—		6,709,961		—		6,709,961
Common stock issued for payment of Series B Preferred Stock dividend	101,471	102		—	—		166,669				166,771
Net loss	—	—		—	—		—		(37,817,959)		(37,817,959)
Balance, September 30, 2019	66,189,613	$	66,190	—	$	—	$	141,030,711	$	(179,461,662)	$	(38,364,761)

See accompanying notes to the condensed consolidated financial statements.

Workhorse Group Inc.

Condensed Consolidated Statements of Cash Flows

For the ~~Six~~Nine Months Ended ~~June~~September 30, 2019 and 2018

(Unaudited)

2019 2018
Cash flows from operating activities:
Net loss $ (43,120,485 ) $ (13,327,103 )
Adjustments to reconcile net loss to cash used by operations:
Depreciation 193,786 152,525
Amortization of Marathon loan issuance costs 260,103 -
Amortization of discount on Series B preferred stock 119,471 -
Amortized discount and debt issuance costs on Senior Secured Notes - 987,500
Stock-based compensation 876,918 548,263
Inventory obsolescence reserve 22,221 -
Change in fair value of warrants 31,706,780 -
Effects of changes in operating assets and liabilities:
Accounts receivable and lease receivable 24,135 842,798
Inventory 313,712 (342,727 )
Prepaid expenses and deposits 554,276 765,043
Accounts payable and accrued liabilities (2,228,965 ) 1,980,433
Warranty (485,209 ) -
Notes payable, related parties - 550,000
Customer deposits (47,000 ) 265,595
Net cash used by operating activities (11,810,257 ) (7,577,673 )

Cash flows from investing activities:
Capital expenditures (2,965,372 ) -
Net cash used by investing activities (2,965,372 -

Cash flows from financing activities:
Payments on long-term debt - (16,770 )
Proceeds from revolving loans 5,854,140 -
Proceeds from issuance of series B preferred stock
25,000,000 -
Issuance of common stock 5,928,235 4,021,341
Exercise of warrants and options - 90,066
Net cash provided by financing activities 36,782,375 4,094,637

Change in cash and cash equivalents 22,006,746 (3,483,036 )
Cash and cash equivalents, beginning of the period 1,512,750 4,069,477
Cash and cash equivalents, end of the period $ 23,519,496 $ 586,441


	2019		2018
Cash flows from operating activities:
Net loss	$	(37,817,959)	$	(18,812,656)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	291,287		251,886
Amortization of discount and debt issuance costs on long-term debt	850,800		1,576,005
Amortization of discount on Series B preferred stock	482,589		—

Stock-based compensation	1,213,602		803,226
Other	41,588		28,645
Change in fair value of warrants	18,935,392		(1,527,414)
Effects of changes in operating assets and liabilities:
Lease receivable	33,863		1,016,631
Inventory, net	122,407		(316,411)
Prepaid expenses and deposits	(4,538,704)		409,723
Accounts payable and accrued liabilities	(3,128,203)		(1,065,124)
Warranty liability	(551,798)		—

Customer deposits	(72,000)		309,595
Net cash used in operating activities	(24,137,136)		(17,325,894)

Cash flows from investing activities:
Capital expenditures	(4,001,838)		(131,318)
Proceeds on disposition of property, plant and equipment	5,000		4,800
Net cash used in investing activities	(3,996,838)		(126,518)

Cash flows from financing activities:
Payments on long-term debt	—		(7,841,378)
Proceeds from long-term debt	5,854,140		7,800,000
Payment of loan issuance costs	—		(70,047)
Proceeds from issuance of series B preferred stock	25,000,000		—
Issuance of common stock	5,928,235		16,398,662
Exercise of warrants and options	—		90,066
Net cash provided by financing activities	36,782,375		16,377,303

Change in cash, cash equivalents and restricted cash	8,648,401		(1,075,109)
Cash, cash equivalents and restricted cash, beginning of the period	1,512,750		4,069,477
Cash, cash equivalents and restricted cash, end of the period	$	10,161,151	$	2,994,368

The following table provides a reconciliation of cash, cash equivalents and restricted cash to the amounts reported within the condensed consolidated balance sheet:


	September 30,
	2019		2018
Cash and cash equivalents	$	9,261,151	$	2,994,368
Restricted cash	900,000		—
Total cash, cash equivalents and restricted cash	$	10,161,151	$	2,994,368

See accompanying notes to condensed consolidated financial statements.

Workhorse Group Inc.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1.	~~SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES~~

1.SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES

The following accounting principles and practices are set forth to facilitate the understanding of ~~data~~information presented in the condensed consolidated financial ~~statements:~~

statements.

Nature of operations and principles of consolidation

Workhorse Group Inc. (“Workhorse”, the “Company”, “we”, “us” or “our”) is a technology company focused on providing sustainable and cost-effective solutions to the commercial transportation sector. As an American manufacturer, we design and build high performance battery-electric vehicles and aircraft that make movement of people and goods more efficient and less harmful to the environment. As part of our solution, we also develop cloud-based, real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. ~~Although we operate as a single unit through our subsidiaries, we approach our development through two divisions, Automotive and Aviation.~~ We are currently focused on ~~our core competency of~~ bringing the N-GEN electric cargo van to market and fulfilling our existing backlog of orders. We are also exploring other opportunities in monetizing our intellectual property which could include a sale, license or other arrangement of assets that are outside of our core focus.

~~The Company’s wholly owned subsidiaries include Workhorse Technologies Inc., Workhorse Motor Works Inc., Workhorse Properties Inc. and Surefly, Inc~~

On May 3, 2019, the Company filed an amendment to its Articles of Incorporation to increase its authorized shares of common stock from 100,000,000 to 250,000,000.

Basis of presentation

The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has limited revenues and a history of negative working capital and stockholders’ deficits. Our existing capital resources are expected to be sufficient to fund our operations through the end of 2019. Unless and until we are able to generate a sufficient amount of revenue, reduce our costs and/or enter a strategic relationship, we expect to finance future cash needs through public and/or private offerings of equity securities ~~and /or~~and/or debt financings. If we are not able to obtain additional financing and/or substantially increase revenue from sales, we will be unable to continue as a going concern. These conditions raise substantial doubt about the ability of the Company to continue as a going concern.

In view of these matters, continuation as a going concern is dependent upon the continued operations of the Company, which, in turn, is dependent upon the Company’s ability to meet its financial requirements, raise additional capital, meet its future ~~bank~~debt covenant requirements, and successfully carry out its future operations. The financial statements do not include any adjustments to the amount and classification of assets and liabilities that may be necessary, should the Company not continue as a going concern.

The Company has continued to raise capital. Management believes the proceeds from these offerings, future offerings, and the Company’s anticipated revenue, provides an opportunity to continue as a going concern. If additional funding is required, the Company plans to obtain working capital from either debt or equity financing from the sale of common stock, preferred stock, and/or convertible debentures. Obtaining such working capital is not assured. The Company is currently in a production ramp up mode and placing greater emphasis on manufacturing capability.

The Marathon Credit Facility includes financial covenants that require our compliance beginning in the fourth quarter of 2019. We expect to be able to satisfy the covenant requirements either through results of operations or ~~the~~an available ~~Equity Cure~~equity cure in the Credit Agreement.

In the opinion of Management, the Unaudited Condensed Consolidated Financial Statements include all adjustments that are necessary for the fair presentation of Workhorse’s financial conditions, results of operations and cash flows for the interim periods presented. Such adjustments are of a normal, recurring nature. Intercompany balances and transactions are eliminated in consolidation. The results of operations and cash flows for the interim periods presented may not necessarily be indicative of full-year results. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto of Workhorse contained in its Annual Report onForm 10-K for the year ended December 31, 2018.

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

Certain reclassifications were made to the prior year financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operation or stockholders’ equity (deficit).

2.	~~INVENTORY~~

~~As of June 30, 2019, and December 31, 2018, our inventory consisted~~

2. INVENTORY

Inventory consists of the following:

2019 2018
Raw materials $ 4,285,830 $ 4,319,637
Work in process 422,176 702,079
Finished goods - -
4,708,006 5,021,716
Less: Inventory reserve 2,510,323 2,488,100
$ 2,197,683 $ 2,533,616

3.	~~REVENUE~~

September 30, 2019 December 31, 2018
Raw materials $ 4,478,201 $ 4,319,637
Work in process 422,176 702,079
Finished goods — —
4,900,377 5,021,716
Less: Inventory reserve 2,511,389 2,488,100
Total inventory, net $ 2,388,988 $ 2,533,616

3. REVENUE

Revenue Recognition

Net sales include products and shipping and handling charges, net of estimates for customer allowances. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with the majority of revenue recognized at the point in time the customer obtains control of the products. We recognize revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. The majority of our contracts have a single performance obligation and are short term in nature.

Accounts Receivable

Credit is extended based upon an evaluation of the customer’s financial condition. Accounts receivable are stated at their estimated net realizable value. The allowance for doubtful accounts is based on an analysis of customer accounts and our historical experience with accounts receivable write-offs.

The Company has elected the following practical expedient allowed under ASU 2014-09. Performance obligations are satisfied within one year from a given reporting date, consequently we omit disclosure of the transaction price apportioned to remaining performance obligations on open ~~orders~~

orders.

Disaggregation of Revenue

Our revenues related to the following types of business were as ~~follows for the periods ended June 30:~~

Three Months Ended
June 30, Six Months Ended
June 30,
2019 2018 2019 2018

Automotive $ - $ 118,398 $ 240,000 $ 523,252
Aviation - - - -
Other 5,508 52,286 129,690 207,661
Total revenues $ 5,508 $ 170,684 $ 369,690 $ 730,913

4.	~~LONG-TERM DEBT~~

follows:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2019		2018		2019		2018
Automotive	$	—	$	—	$	240,000	$	523,252
Aviation	—		—		—		—
Other	4,258		10,997		133,948		218,658
Total revenues	$	4,258	$	10,997	$	373,948	$	741,910

4. LONG-TERM DEBT

Long-term debt consists of the following:

June 30,
2019 December 31,
2018
Marathon Tranche One Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019 $ 10,000,000 $ 10,000,000
Marathon Tranche Two Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019 5,854,140 -
Marathon Credit Agreement unamortized discount and issuance costs (1,427,818 ) (1,687,921 )
Net Marathon Credit Agreement 14,426,322 8,312,079
Less current portion 5,854,140 -
Long-term debt $ 8,572,182 $ 8,312,079


	September 30, 2019		December 31, 2018
Marathon Tranche One Loan, due December 31, 2021, interest payable quarterly, variable interest rate of 10.0% as of September 30, 2019	$	10,000,000	$	10,000,000
Marathon Tranche Two Loan, due December 31, 2021, interest payable quarterly, variable interest rate of 10.0% as of September 30, 2019	5,854,140		—
Unamortized discount and issuance costs	(1,294,730)		(1,687,921)
Net Marathon Credit Agreement	14,559,410		8,312,079
Less current portion	6,354,140		—
Long-term debt	$	8,205,270	$	8,312,079

On December 31, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”), with Marathon Asset Management, LP, on behalf of certain entities it manages, as lenders (collectively, the “Lenders”). The Credit Agreement ~~provided~~provides the Company with a $10 million ~~tranche of~~ term ~~loans~~loan (the “Tranche One Loan”) which may not be re-borrowed following repayment and (ii) a $25 million ~~tranche of~~ revolving ~~loans~~loan which may be re-borrowed following repayment (the “Tranche Two ~~Loans”~~Loan” together with the Tranche One Loan, the “Loans”).

The Tranche One Loan requires principal payments of $0.5 million on June 30, 2020, December 31, 2020 and June 30, 2021 with the remaining balance due on December 31, 2021. The Tranche Two Loan matures on December 31, 2021.

The Trance Two Loan has been classified as current, ~~debt,~~ because the agreement includes a lock box and cash sweep feature, which requires current presentation of the debt.

~~Second Amendment to~~

The Credit Agreement

~~On April 1, 2019,~~ requires the Company ~~entered into~~to maintain certain financial covenants including:

a.Maintaining a minimum of $4.0 million of liquidity;

b.Maintaining as of December 31, 2019 a total leverage ratio (ratio of total debt to EBITDA for the ~~Second Amendment~~preceding four quarters) not to exceed 4.50:1.00. The total leverage ratio is adjusted in subsequent quarters as set forth in the Credit Agreement; and

c.The debt service coverage ratio (ratio of EBITDA for the last four quarters, subject to certain adjustments as defined in the Credit Agreement, ~~(the “Marathon Second Amendment”) with~~to interest expense and payments for operating leases), not to exceed 1.25:1.00 as of December 31, 2019. The debt service coverage ratio is adjusted in subsequent quarters as set forth in the ~~Lenders. The Marathon Second Amendment delayed~~Credit Agreement.

If the ~~application of certain~~Company is unable to meet its financial covenants ~~including:~~

~~(i)~~

the ~~minimum liquidity, providing that at least $4 million must be maintained at all times on or after April 30, 2019 rather than beginning on March 31, 2019;~~

~~(ii)~~

the maximum total leverage ratio (ratio of total debt borrowed by the Company and its subsidiaries to EBITDA), providing that the maximum total leverage ratio shall not exceed 4.50:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter ending September 30, 2019, which total leverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement; and

~~(iii)~~

the maximum debt service coverage ratio (ratio of EBITDA (for the four consecutive fiscal quarters most recently ended, subject to certain adjustments set forth in the Credit Agreement) to interest expense and payments for operating leases), providing that the maximum debt service coverage ratio shall not exceed 1.25:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter ending September 30, 2019, which debt service coverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement.

~~Third Amendment to~~ Credit Agreement

~~On April 30, 2019,~~ has an equity cure available which can be used to satisfy the covenants.

The Tranche Two Loan requires that as long as there are amounts outstanding under the loan, that the Company ~~entered into the Third Amendment to Credit Agreement (the “Marathon Third Amendment”). The Marathon Third Amendment amended the minimum liquidity covenant, providing that at least $4~~maintains $0.9 million must be maintained at all times at or after May 31, 2019 rather than at all times on or after April 30, 2019. Unless the Company fails to maintain minimum liquidity as of the last day of any calendar month, the Company may curein a ~~failure to maintain minimum liquidity by increasing liquidity to $4.0 million within five business days of the occurrence.~~

restricted cash account.

Purchase Warrants

In conjunction with entering into the Credit Agreement, the Company issued ~~each Lender a~~ Common Stock Purchase ~~Warrant~~Warrants (“Initial Warrants”) to purchase ~~in the aggregate,~~ 8,053,390 shares of common stock at an exercise price of $1.25 per ~~share~~share. The Initial Warrants are exercisable infor cash only ~~for a period of three years~~through December 31, 2021 and then for cash or cashless ~~thereafter (collectively, the “Initial Warrants”).~~thereafter. Until the later of the repayment of all ~~obligations owed to~~amounts outstanding under the ~~Lenders~~Credit Agreement or ~~two years from the closing date,~~December 31, 2021, the Company ~~will be required to~~must issue additional ~~Common Stock Purchase~~ Warrants ~~(the “Additional Warrants”)~~ to the Lenders equal to 10%, in the aggregate, of any additional equity issuances ~~subject to certain exceptions,~~ on substantially the same terms and conditions of the Initial Warrants, except that (i) the ~~applicable~~ expiration date ~~thereof~~ shall be five years from the issuance date, ~~of the applicable warrant,~~ (ii) the ~~initial~~ exercise price shall be ~~a price~~ equal to 110% of the issuance price per share ~~of common stock used~~ in the relevant issuance, ~~multiplied by 110%,~~ and (iii) the holder shall be entitled to exercise the warrant on a cashless ~~exercise~~basis at any ~~time the warrant is exercisable.~~

time.

On April 16, 2019, the Company entered into an Amendment No. 1 to the Common Stock Purchase Warrants with ~~Marathon Asset Management LP, on behalf of certain entities it manages, as warrant holders~~the Lenders (collectively, the “Holders”) ~~(collectively, the~~(the “Marathon Warrant Amendment”)~~, amending certain terms of the existing warrants issued by the Company in favor of each Holder.~~. Pursuant to the Marathon Warrant Amendment, unless the Company has obtained the approval of its shareholders, then the number of shares to be issued under warrants held by the Holders shall not exceed 19.99% of the issued and outstanding common stock of the

Company as of December 31, 2018. The Marathon Warrant Amendment also ~~provide~~provides that the failure to obtain shareholder approval of an increase in the number of authorized shares of common stock of the Company, sufficient to enable the Company to issue common stock upon exercise of the warrants held by each Holder, will constitute an event of default under the ~~existing~~ Credit Agreement.

~~The warrants~~

Currently the Initial Warrants are classified as liability financial instruments and required to be ~~marked to market~~marked-to-market at each balance sheet date with a corresponding charge to interest expense. As of ~~June~~September 30, 2019 and December 31, 2018, the warrant liability for the Initial Warrants was ~~$33,529,599~~$19,901,139 and ~~$1,822,819,~~$965,747, respectively.

~~DUKE FINANCING OBLIGATION~~

Any additional warrants issued in connection with Credit Agreement have been classified as equity instruments and are not required to be marked-to-market at each balance sheet date.

The Company has outstanding warrants issued to Arosa for debt issued in 2018. The Arosa debt was subsequently paid off on December 31, 2018, with the proceeds from the Credit Agreement. Through and including December 31, 2018, the warrants held by Arosa were required to be marked-to-market as the warrants were classified as liabilities. On January 1, 2019, the warrants no longer included dilution protection and therefore no longer met the criteria for liability classification and were reclassified to equity. As a result of the reclassification event, the $857,072 warrant liability for the Arosa warrants was reclassified to additional paid-in capital in 2019.

5. DUKE FINANCING OBLIGATION

On November 28, 2018, the Company entered into a Sales Agreement with Duke Energy One, Inc (“Duke”) pursuant to which the Company sold Duke 615,000 battery cells (the “615,000 Cells”) ~~in consideration of~~for $1,340,700. The Company will continue to use the cells in the near term for the delivery of trucks to ~~UPS and DHL.~~customers. Until October 15, 2019, the Company has the right and option to require Duke to sell the 615,000 Cells back to the Company and Duke has the right and option to require the Company to purchase the 615,000 Cells at price equal to the price the 615,000 Cells were sold.

On October 14, 2019, the Company exercised its option to purchase the 615,000 Cells at a price of $2.18 per cell which will close on December 1, 2019.

The Duke transaction was accounted for as a financing obligation and the Company has recorded a $1,340,700 liability.

On November 28, 2018, in consideration for consenting to the Company selling the 615,000 Cells to Duke, which served as collateral for Arosa for their Loan Agreement, the Company ~~entered into a Limited Consent, Waiver and Release pursuant to which the Company~~ issued Arosa 2,000,000 shares of common stock and restruck the exercise price of warrants previously issued to $1.25 per share.

~~The Duke transactions was accounted for as a financing obligation and as such, the Company has recorded a $1,340,700 liability related to the transaction.~~

~~MANDATORY REDEMABLE SERIES B PREFERRED STOCK~~

~~Commencing May 31, 2019 through~~

6. MANDATORY REDEEMABLE SERIES B PREFERRED STOCK

On June 5, 2019 ~~(“Closing~~(the “Closing Date”), the Company ~~entered into~~closed Subscription Agreements with institutional investors ~~pursuant to which~~for the ~~investors purchased~~purchase of 1,250,000 units consisting of one share of Series B Preferred Stock (the “Preferred Stock”), with a stated value of $20.00 per share (the “Stated Value”) and a common stock purchase warrant to purchase 7.41 shares of the common stock (the “Warrants”) for an aggregate of purchase price of $25.0 million.

The Preferred Stock is not convertible and does not hold voting rights.

The Preferred Stock ranks senior to the Company’s common stock with respect to dividend rights and rights upon liquidation, winding-up or dissolution. The Preferred Stock is entitled to annual dividends at a rate equal to 8.0% per annum on the Stated ~~Value of the Preferred Stock.~~Value. Accrued dividends will be payable quarterly in shares of common stock of the Company based on a fixed share price of $1.62. The Warrants have an exercise price of $1.62 per share, which was in excess of the closing price of $1.60 on May 30, ~~2019, and~~2019. They are immediately exercisable and will expire seven years from the date of issuance.

~~The Preferred Stock is not convertible and does not hold voting rights.~~

~~On the fourth anniversary of the Closing Date,~~

In June 2023, the Company is required to redeem all the outstanding shares of the Preferred Stock at the Stated Value, plus accrued and unpaid dividends. At any time prior to such date, the Company, subject to the repayment and retirement of the Credit Agreement, may redeem any outstanding shares of Preferred Stock at the Stated Value, plus accrued and unpaid dividends (“Optional Redemption”). Notwithstanding the foregoing, the Company may elect an Optional Redemption prior to the fourth anniversary of the Closing Date so long as it obtains from the lenders to the Credit Agreement ~~their prior written~~ consent to such Optional Redemption.

The aggregate number of shares of common stock issued in payment of dividends on the Preferred Stock when added to the number of shares of common stock issued upon exercise of any warrants shall not exceed 19.9% of either (a) the total number of shares of common stock outstanding on the date ~~hereof~~hereof; or (b) the total voting power of the Company’s securities outstanding on the date hereof that are entitled to vote on a matter being voted on by holders of the common stock, unless and until the Company obtains stockholder approval permitting such issuances.

As the Preferred Stock is mandatorily redeemable, it is ~~presented~~classified as a liability on the condensed consolidated balance sheet. All dividends payable on the Preferred Stock are classified as interest expense.

The Preferred Stock and Warrants have been determined to be freestanding financial instruments and have been accounted for separately. The Warrants are considered equity instruments and are not required to be recorded as a liability and marked-to-market at each reporting period. On the date of issuance, the value of the Warrants was ~~determined to be~~ $6.7 million, which was determined using the Black-Scholes valuation model. The fair value of the warrants was recorded as an increase to Additional Paid-In Capital and a discount of the Preferred Stock. The discount will be amortized to interest expense through May 2023.

7.	~~STOCK-BASED COMPENSATION~~

~~Options to directors, officers, consultants and employees~~

7. STOCK-BASED COMPENSATION

The Company maintains, as adopted by the board of directors, the 2019 Stock Incentive Plan as well as previous years plans (the “Plans”) providing for the issuance of equity based awards to employees, officers, directors or consultants of the Company. Non-qualified stock options granted under the plans may only be granted with an exercise price equal to the fair market value of the Company’s common stock on the date of grant. Awards under the plans may be either vested or unvested options.

In addition to the awards issued under the Plans, the Company has granted, on various dates, stock options to directors, officers, consultants and employees to purchase common stock of the Company. The terms, exercise prices and vesting of these awards vary.

The following table summarizes option activity for directors, officers, consultants and employees:

Outstanding Stock Options
Options Available for Grant Number of Options Outstanding Weighted
Average
Exercise Price
per Option Weighted
Average Grant
Date Fair Value
per Option Weighted
Average
Remaining
Exercise Term
in Months
Balance, December 31, 2017 4,145,774 3,851,371 $ 3.11 $ 1.84 43
Granted (340,000 ) 340,000 1.18 0.54 56
Exercised -   (52,500 ) 1.24 0.68 -
Forfeited -   -   -   -   -
Expired -   (271,250 ) 3.22 1.58 -
Balance, December 31, 2018 3,805,774 3,867,621 4.05 $ 1.84 64
Additional Shares Authorized under 2019 Plan 8,000,000 -
Granted (2,400,000 ) 2,400,000 0.96 0.53 81
Exercised -   (498,552 ) 0.13 1.92
Forfeited 1,375,069 (1,375,069 ) 4.75 1.95 27
Expired -   -
Balance, June 30, 2019 10,780,843 4,394,000 $ 2.60 $ 1.32 94

~~INCOME TAXES~~


		Outstanding Stock Options
	Options Available for Grant	Number of Options Outstanding	Weighted Average Exercise Price per Option		Weighted Average Grant Date Fair Value per Option		Weighted Average Remaining Exercise Term in Months
Balance, December 31, 2017	4,145,774	3,851,371	$	3.11	$	1.84	43
Granted	(340,000)	340,000	1.18		0.54		56
Exercised	—	(52,500)	1.24		0.68		—

Forfeited and expired	—	(271,250)	3.22		1.58		—
Balance, December 31, 2018	3,805,774	3,867,621	4.05		1.84		64
Additional Shares Authorized under 2019 Plan	8,000,000	—
Granted	(2,400,000)	2,400,000	0.96		0.53		81
Exercised	—	(497,552)	0.12		0.97		—

Forfeited and expired	1,774,069	(1,774,069)	4.85		1.97		—
Balance, September 30, 2019	11,179,843	3,996,000	$	2.33	$	1.12	66

8. INCOME TAXES

As the Company has not generated taxable income since inception, the cumulative deferred tax assets remain fully reserved, and no provision or liability for federal or state income taxes has been included in the financial statements.

~~EARNINGS PER SHARE~~

9. EARNINGS PER SHARE

Basic loss per share is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted earnings per share are calculated using the treasury stock method, on the basis of the weighted average number of shares outstanding plus the dilutive effect, if any, of stock options and warrants. For all periods presented, due to the Company’s net losses, all of the ~~Company’s~~ common stock equivalents were anti-dilutive and excluded from the calculation of diluted loss per ~~share because they were anti-dilutive.~~

~~10.~~

~~RECENT ACCOUNTING DEVELOPMENTS~~

share.

The following table shows the computation of basic and diluted earnings per share:

Three Months Ended September 30, Nine Months Ended September 30,
2019 2018 2019 2018
Net loss $ (11,493,587) $ (5,485,553) $ (37,817,959) $ (18,812,656)
Deemed dividends — — 86,207 765,179
Net loss attributable to common shareholders $ (11,493,587) $ (5,485,553) $ (37,904,166) $ (19,577,835)
Basic weighted average shares outstanding 66,176,921 46,192,471 63,566,295 46,192,471
Dilutive effect of options and warrants — — — —
Diluted weighted average shares outstanding 66,176,921 46,192,471 63,566,295 46,192,471
Anti-dilutive options and warrants excluded from diluted average shares outstanding 32,917,619 4,558,927 32,917,619 4,558,927

10. RECENT ACCOUNTING DEVELOPMENTS

Accounting Guidance Adopted in 2019

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which requires a lessee to recognize in the statement of financial position a liability to make lease payments (“the lease liability”) and a right-of-use asset representing its right to use the underlying asset for the lease term, initially measured at the present value of the lease payments. A lessee shall classify a lease as a finance lease or an operating lease.

Amortization of the right-of-use asset shall be on a straight-line basis, unless another basis is more representative of the pattern in which the lessee expects to consume the right-of-use asset’s future economic benefits. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases ~~generally~~ on a straight-line basis over the lease term. The amendments in this update were applied using the current period adjustment method ~~as defined, and were effective~~ on January 1, 2019. The adoption of this standard did not have a material impact on the condensed consolidated financial statements.

~~11.~~

~~SHARE HOLDERS EQUITY (DEFICIT)~~

11. SHARE HOLDERS EQUITY (DEFICIT)

2018 Stock Offerings

On June 22, 2017, the Company entered into an at the market issuance sales agreement with Cowen and Company, LLC (“Cowen”) under which the Company may offer and sell shares of its Common Stock having an aggregate offering price of up to $25 million. For the nine months ended September 30, 2019 and 2018, the Company issued 1,609,373 and 1,794,621 shares under this agreement for net proceeds of approximately $1.5 million and $3.7 million, respectively. This agreement was canceled in the first quarter of 2019.

On April 26, 2018, the Company closed Subscription Agreements with accredited investors (the “April 2018 Accredited Investors”) who purchased 531,066 shares of the Company’s common stock for a purchase price of $1.4 million or $2.72 per share. Stephen Burns, Benjamin Samuels, Gerald Budde and Julio Rodriguez, executive officers and/or directors of the Company at the time of the offering, participated in this offering.

On June 4, 2018, the Company and holders of all outstanding Warrants to Purchase Common Stock of the Company issued on September 18, 2017 (collectively, the “Warrants”) entered into ~~separate, privately-negotiated~~ exchange agreements, ~~(the “Exchange Agreements”),~~ pursuant to which the Company issued ~~an aggregate of~~ 1,968,736 shares of the Company’s common stock in exchange for the Warrants. In ~~addition,~~the second quarter of 2018, the “Down Round” feature of the Warrants was triggered, ~~in the second quarter of 2018,~~ causing the strike price to decrease from $3.80 per share to $2.62 per share. As a result, the Company recorded a deemed dividend of $765,179 which represents the fair value transferred to the Warrant holders from the Down Round feature being triggered. The deemed dividend was recorded as a reduction of Retained Earnings and increase in Additional Paid-in-Capital and ~~reduced~~increased the net ~~income available~~loss to common shareholders by the same amount.

~~Commencing February 11, 2019,~~

On August 9, 2018, the Company entered into an Underwriting Agreement with National Securities Corporation (the "Underwriter"), for the public offering of 9,000,000 shares of our Common Stock at a price per share of $1.15 for net proceeds of $9.6 million. On August 14, 2018, the Underwriter exercised its over-allotment option and ~~closed Subscription Agreements with accredited~~sold an additional 1,288,800 shares of Common Stock at a price per share of $1.15 for net proceeds of $1.4 million.

2019 Stock Offerings

In February 2019, the Company sold 1,616,683 shares of common stock to investors (the “February 2019 ~~Accredited~~ Investors”) for ~~the purchase~~net proceeds of ~~1,613,683 shares of the Company’s common stock for a purchase price of $1,465,056. If, prior to the six month anniversary,~~$1.5 million. Through July 2019, if the Company ~~issues~~issued shares of its common stock for a ~~purchase~~ price per share less than the ~~purchase~~ price paid by the February 2019 ~~Accredited~~ Investors (a “Down Round”), the Company ~~will~~was required to issue additional shares of common stock (for no additional consideration) such that the effective purchase price per share is equal to the purchase price per share paid in the Down Round. ~~The Down Round provisions were triggered by the~~On May 1, 2019 ~~sale~~the Down Round provision of ~~common stock~~the agreement was triggered and an additional 116,496 shares of common stock were issued to the February 2019 ~~Accredited~~ Investors. The issuance of the additional shares iswas accounted for as a $86,207 deemed dividend.

The deemed dividend was recorded as a reduction of Retained Earnings and increase in Additional Paid-in-Capital and increased the net loss to common shareholders by the same amount.

Benjamin Samuels and Gerald Budde, directors of the Company, acquired 841,928 and 26,310 shares of common stock, respectively, as part of ~~this~~the February 2019 offering at a price per share ~~purchase was~~of $0.9501, which was above the closing price the date prior to close. They did not receive the Down Round protection.

On May 1, 2019, the Company closed ~~under~~ a registered public offering for the sale of 3,957,432 shares of Common Stock for a purchase price of $0.74 per share. The net proceeds to the Company were approximately $2.9 million, after deducting estimated expenses payable by the Company. The Company expects to use the net proceeds from this offering for working capital, general corporate purposes and repayment of debt and other obligations.

million.

Warrants

In connection with the issuance of debt and preferred stock, the Company has issued warrants to purchase ~~share~~shares of the Company's Common Stock.

The following table summarizes warrant activity for the period:

Number of Warrants Weighted Average Exercise Price per Warrant Weighted Average Remaining Exercise Term in Months
Balance, December 31, 2018 17,818,844 $ 1.84 52
Granted, Series B Preferred Stock 9,262,500 1.62 48
Granted, Marathon debt 1,840,275 1.40 60
Exercised -
Balance, June 30, 2019 28,921,619 $ 2.58 69

~~12.~~

~~SUBSEQUENT EVENTS~~


	Number of Warrants	Weighted Average Exercise Price per Warrant		Weighted Average Remaining Exercise Term in Months
Balance, December 31, 2018	17,818,844	$	1.84	52
Granted, Series B Preferred Stock	9,262,500	1.62		48
Granted, Marathon debt	1,840,275	1.40		60
Exercised	—
Balance, September 30, 2019	28,921,619	$	1.74	49

12. SUBSEQUENT EVENTS

The Company evaluates events and transactions occurring subsequent to the date of the condensed consolidated financial statements for matters requiring recognition or disclosure in the condensed consolidated financial statements. The accompanying condensed consolidated financial statements consider events through the date on which the condensed consolidated financial statements were available to be issued.

SureFly

On October 1, 2019, the Company entered into an agreement for the sale of SureFly™ for $4.0 million. The completion of the sale is contingent on receiving approval from the Lenders of the Credit Agreement.

Hackney

On October 31, 2019, the Company and ST Engineering Hackney, Inc. ("Seller") entered into an Asset Purchase Agreement (the "Purchase Agreement") to purchase certain assets of Seller (the "Acquired Assets") and assume certain liabilities of Seller. The closing under the Purchase Agreement provides that the Company will be required to deliver shares of its common stock to the Seller if it does not make the Second Payment (as defined below) on a timely basis. Accordingly, upon execution of the Purchase Agreement, the Company deposited $1.0 million in cash and shares of its common stock having an aggregate value of $6.6 million based on the closing price as of the day immediately preceding the date of the Purchase Agreement (the "Escrow Shares") into an escrow account (the "Escrow Account"). The number of Escrow Shares shall be subject to adjustment if the aggregate value of the Escrow Shares is less than $5.28 million or greater than $7.92 million on certain dates.

The Company agreed to pay $7.0 million for the purchase of the Acquired Assets, $1.0 million of which shall be payable from the Escrow Account upon satisfaction of certain conditions, and the remaining $6.0 million of which (the “Second Payment”) shall be payable in cash within 45 days if certain additional conditions are attained. The Purchase Agreement provides that the Company shall make additional payments to Seller in the event the Second Payment is not made within 45 days of when such payment is due. In the event the Second Payment is not made to Seller within 105 days after such payment is due, Seller may, at its option, require that the Escrow Agent release to Seller Escrow Shares with a value (based on the then-current market price of the shares) equal to $6,000,000 in satisfaction of the Second Payment.

Lordstown Motors

On November 7, 2019, the Company entered into a transaction with Lordstown Motors Corp. (“LMC”) pursuant to which the Company agreed to grant LMC a perpetual and worldwide license to certain intellectual property relating to the Company’s W-15 electric pickup truck platform and its related technology (the “Licensed Intellectual Property”) in exchange for royalties, equity interests in LMC, and other consideration (the “LMC Transaction”). LMC was founded

by Stephen S. Burns (“Mr. Burns”), a current stockholder and former Chief Executive Officer and Director of the Company.

In connection with the LMC Transaction, the following agreements (collectively, the “Agreements”) were entered into:

•Intellectual Property License Agreement between the Company and LMC (the “License Agreement”);

•Subscription Agreement between the Company and LMC (the “Subscription Agreement”);

•Voting and Registration Rights Agreement among the Company, LMC, and certain LMC stockholders (the “Voting Agreement”); and

•Consent and Waiver to Credit Agreement among the Company, Wilmington Trust, as agent, and the lenders under the Credit Agreement (defined below) (the “Consent and Waiver”).

LMC will endeavor to, among other things, raise sufficient third-party capital for the acquisition, retrofitting, and restart of the Lordstown Assembly Complex, and the ongoing operating costs, which amounts are expected to be significant (the “Capital Raise”). The Agreements provide that LMC would manufacture electric pickup trucks or similar vehicles under 10,001 gross vehicle weight (GVW) using the Licensed Intellectual Property (the “Vehicles”).

Under the Agreements, LMC has exclusive rights to the Licensed Intellectual Property from the date of the License Agreement until the earliest of: (i) June 30, 2020, if the Capital Raise has not occurred; (ii) the second anniversary of the LMC Transaction, if LMC has not started regularly manufacturing Vehicles; (iii) the third anniversary of the LMC Transaction; and (iv) the date that any third-party automotive manufacturer acquires more than ten percent of LMC’s outstanding common stock. The Licensed Intellectual Property excludes the Company’s intellectual property relating to cargo vans for last-mile delivery or commercial use. LMC will have the right, with limited exceptions, to match the best competing offer as a subcontractor for the Company should need to engage a subcontractor in connection with larger potential production contracts to assemble such vehicles utilizing its existing capabilities and technologies. The limited exceptions include the event in which the Company elects to award a subcontract for the manufacturing or assembly to a strategic partner owning in excess of 19% of the Company.

LMC must pay the Company 1 percent of the aggregate debt and equity commitments funded to LMC upon completion of the Capital Raise (the “Royalty Advance”). LMC must also pay a 1 percent royalty on the gross sales price of the first 200,000 Vehicles sold, but only to the extent that the aggregate amount of such royalty fees exceed the amount paid as the Royalty Advance. Upon completion of the Capital Raise, the Company intends to transfer its approximately 6,000 existing orders for Vehicles to LMC, subject to customer consent. LMC will pay the Company a four percent commission on the gross sales price of any transferred existing orders fulfilled by LMC. The success of the Capital Raise is not within the Company’s control, and it therefore cannot provide assurance that it will receive the Royalty Advance or receive the projected underlying royalty from the production of Vehicles.

Under the Subscription Agreement, LMC agreed to issue 10 percent of its common stock to the Company in exchange for the Company’s obligations under the License Agreement. The Subscription Agreement grants the Company anti-dilution rights for two years. The Company is subject to certain restrictions on transferring LMC’s equity for this two-year period. Under the Voting Agreement, the Company has the right to designate 1 director to LMC’s board of directors, subject to certain limitations.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview and Quarter Highlights

We are a technology company focused on providing sustainable and cost-effective solutions to the commercial transportation sector. As an American manufacturer, we design and build high performance battery-electric vehicles and aircraft that make movement of people and goods more efficient and less harmful to the environment. As part of our solution, we also develop cloud-based, real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. Although we operate as a single unit through our subsidiaries, we approach our development through two divisions, Automotive and Aviation. We are currently focused on our core competency of bringing the N-GEN electric cargo van to market and fulfilling our existing backlog of orders. We are also exploring other opportunities in monetizing our intellectual property which could include a sale, license or other arrangement of assets that are outside of our core focus.

Workhorse electric delivery vans ~~are currently in production and~~ are in use by our customers on U.S. roads. Our delivery customers include companies such as UPS, FedEx Express, Alpha Baking and W.B. Mason. Data from our in-house developed telematics system demonstrates our vehicles on the road are averaging approximately a 500% increase in fuel economy as compared to conventional gasoline-based trucks of the same size and duty cycle.

In addition to improved fuel economy, we anticipate that the performance of our vehicles on-route will reduce long-term vehicle maintenance expense by approximately 50% as compared to fossil-fueled trucks.

We are an OEM capable of manufacturing Class 3-6 commercial-grade, medium-duty truck chassis at our Union City, Indiana facility, marketed under the Workhorse® brand. ~~All~~ Workhorse last mile delivery vans are assembled in the Union City assembly facility.

From our development modeling and the existing performance of our electric vehicles on American roads, we estimate that our E-GEN Range-Extended Electric delivery vans will save over $150,000 in fuel and maintenance savings over the 20-year life of the vehicle. ~~Due to the positive return-on-investment, we place a premium price for our vehicles when selling to major fleet buyers.~~ We expect that fleet buyers will be able to achieve a four-year or better ~~return-on-investment~~return-of-investment (without government incentives), which we believe justifies the higher acquisition cost of our vehicles.

Our goal is to continue to increase sales and production, while executing on our cost-down strategy to a point that will enable us to achieve gross margin profitability of the last mile-delivery van platform. As a key strategy, we have developed the Workhorse N-GEN platform, which has been accelerated from our previous development ~~efforts on the USPS Next Generation Delivery Vehicle (“NGDV”) program.~~

efforts.

The Workhorse N-GEN electric cargo van platform will be available in multiple size configurations, 450, ~~700~~650 and 1,000 cubic feet. We intend to initiate the launch with the 450 cubic foot configuration where it is designed to compete with the Sprinter, Transit and RAM ProMaster gasoline/diesel trucks in the commercial sector with an emphasis on last-mile delivery and other service-oriented businesses, such as telecom. This ultra-low floor platform incorporates state-of-the-art safety features, economy and performance. We expect these vehicles offer fleet operators the most favorable total cost-of-ownership of any comparable vehicle available today. We believe we are the first American OEM to market a U.S. built electric cargo van, and early indications of fleet interest are significant. We expect the N-GEN trucks will be supported by our Ryder Systems partnership. Using N-GEN light duty prototypes, we delivered over 100,000 packages in San Francisco and Ohio during our testing. During the period we achieved 50 MPGe and successfully demonstrated the role the vehicle can have in last mile delivery.

As a direct result of the USPS award and development efforts, Workhorse has begun development on the Workhorse W-15, a medium- and light-duty pickup truck platform aimed at commercial fleets. The W-15 pickup truck powertrain is a smaller version of its sister vehicle, the medium-duty battery electric powertrain. Workhorse is currently evaluating licensing opportunities with respect to its W-15 light duty pickup truck platform.

Our HorseFly™ delivery drone is a custom designed, purpose-built drone that is fully integrated in our electric trucks. HorseFly is an octocopter designed with a maximum gross weight of 30 lbs., a 10 lb. payload and a maximum air speed of 50 mph. It is designed and built to be rugged and consisting of redundant systems to further meet the FAA’s required rules and regulations.

SureFly™ is our entry into the emerging VTOL market. It is designed to be a two-person, 400-pound payload aircraft with a hybrid internal combustion/electric power generation system. Our approach in the design is to build the safest and simplest way to fly rotary wing aircraft in the world. We believe it is a practical answer to personal flight, as well as, commercial transportation segments, including air taxi series, agriculture and beyond.

~~The FAA to-date has granted 14 separate Experimental Airworthiness Certifications, registered as N834LW,~~

SureFly

On October 1, 2019, the Company entered into an agreement for the ~~aircraft. These certifications come after an extensive design review and inspection~~sale of SureFly™ for $4.0 million. The completion of the ~~aircraft with each renewed certificate.~~

sale is contingent on receiving approval from the Lenders of the Credit Agreement.

Hackney

The Company agreed to pay $7.0 million for the purchase of the Acquired Assets, $1.0 million of which shall be payable from the Escrow Account upon satisfaction of certain conditions, and the remaining $6.0 million of which (the “Second Payment”) shall be payable in cash within 45 days if certain additional conditions are attained. The Purchase Agreement provides that the Company shall make additional payments to Seller in the event the Second Payment is not made within 45 days of when such payment is due. In ~~November 2018, Workhorse signed cooperative research and development agreement~~the event the Second Payment is not made to Seller within 105 days after such payment is due, Seller may, at its option, require that the Escrow Agent release to Seller Escrow Shares with a ~~branch~~value (based on the then-current market price of the ~~U.S. Military~~shares) equal to ~~test SureFly~~$6,000,000 in satisfaction of the Second Payment.

Lordstown Motors

On November 7, 2019, the Company entered into a transaction with Lordstown Motors Corp. (“LMC”) pursuant to which the Company agreed to grant LMC a ~~specific focus on military applications. This further expands~~perpetual and worldwide license to certain intellectual property relating to the ~~potential market~~Company’s W-15 electric pickup truck platform and its related technology (the “Licensed Intellectual Property”) in exchange for royalties, equity interests in LMC, and other consideration (the “LMC Transaction”). LMC was founded by Stephen S. Burns (“Mr. Burns”), a current stockholder and former Chief Executive Officer and Director of the Company.

In connection with the LMC Transaction, the following agreements (collectively, the “Agreements”) were entered into:

•Intellectual Property License Agreement between the Company and LMC (the “License Agreement”);

•Subscription Agreement between the Company and LMC (the “Subscription Agreement”);

•Voting and Registration Rights Agreement among the Company, LMC, and certain LMC stockholders (the “Voting Agreement”); and

•Consent and Waiver to Credit Agreement among the Company, Wilmington Trust, as agent, and the lenders under the Credit Agreement (defined below) (the “Consent and Waiver”).

LMC will endeavor to, among other things, raise sufficient third-party capital for the ~~aircraft.~~

~~We are continuing with our efforts to consummate a sale~~acquisition, retrofitting, and restart of the ~~SureFly business although we cannot guarantee~~Lordstown Assembly Complex, and the ongoing operating costs, which amounts are expected to be significant (the “Capital Raise”). The Agreements provide that ~~we will be successful in such efforts. We are currently in ongoing negotiations and due diligence procedures with a potential buyer. There are no assurances that these activities will result in~~LMC would manufacture electric pickup trucks or similar vehicles under 10,001 gross vehicle weight (GVW) using the ~~ultimate sale~~Licensed Intellectual Property (the “Vehicles”).

Under the Agreements, LMC has exclusive rights to the Licensed Intellectual Property from the date of the ~~business.~~

License Agreement until the earliest of: (i) June 30, 2020, if the Capital Raise has not occurred; (ii) the second anniversary of the LMC Transaction, if LMC has not started regularly manufacturing Vehicles; (iii) the third anniversary of the LMC Transaction; and (iv) the date that any third-party automotive manufacturer acquires more than ten percent of LMC’s outstanding common stock. The Licensed Intellectual Property excludes the Company’s intellectual property relating to cargo vans for last-mile delivery or commercial use. LMC will have the right, with limited exceptions, to match the best competing offer as a subcontractor for the Company should need to engage a subcontractor in connection with larger potential production contracts to assemble such vehicles utilizing its existing capabilities and technologies. The limited exceptions include the event in which the Company elects to award a subcontract for the manufacturing or assembly to a strategic partner owning in excess of 19% of the Company.

LMC must pay the Company one percent of the aggregate debt and equity commitments funded to LMC upon completion of the Capital Raise (the “Royalty Advance”). LMC must also pay a one percent royalty on the gross sales price of the first 200,000 Vehicles sold, but only to the extent that the aggregate amount of such royalty fees exceed the amount paid as the

Royalty Advance. Upon completion of the Capital Raise, the Company intends to transfer its approximately 6,000 existing orders for Vehicles to LMC, subject to customer consent. LMC will pay the Company a four percent commission on the gross sales price of any transferred existing orders fulfilled by LMC. The success of the Capital Raise is not within the Company’s control, and it therefore cannot provide assurance that it will receive the Royalty Advance or receive the projected underlying royalty from the production of Vehicles.

Under the Subscription Agreement, LMC agreed to issue ten percent of its common stock to the Company in exchange for the Company’s obligations under the License Agreement. The Subscription Agreement grants the Company anti-dilution rights for two years. The Company is subject to certain restrictions on transferring LMC’s equity for this two-year period. Under the Voting Agreement, the Company has the right to designate one director to LMC’s board of directors, subject to certain limitations.

Results of Operations

Our condensed consolidated ~~statement~~statements of operations data ~~for the period presented~~is as follows:

Three Months Ended
September 30, Nine Months Ended
September 30,
2019 2018 2019 2018
Net sales $ 4,258 $ 10,997 $ 373,948 $ 741,910
Cost of sales 1,423,904 1,476,822 3,751,674 4,847,097
Gross loss (1,419,646) (1,465,825) (3,377,726) (4,105,187)
Operating expenses:
Selling, general and administrative 2,551,406 3,363,103 6,638,350 8,766,452
Research and development 1,640,454 1,449,497 4,219,456 5,681,840
Total operating expenses 4,191,860 4,812,600 10,857,806 14,448,292
Loss from operations (5,611,506) (6,278,425) (14,235,532) (18,553,479)
Interest expense, net 5,882,081 (792,872) 23,582,427 259,177
Net loss $ (11,493,587) $ (5,485,553) $ (37,817,959) $ (18,812,656)

Sales

Net sales for the three months ended ~~June~~September 30, 2019 and 2018 were ~~approximately $6,000~~$4,258 and ~~$0.2 million,~~$10,997, respectively. ~~The decrease was primarily due to a decrease in volume of trucks sold.~~

Net sales for the ~~six~~nine months ended ~~June~~September 30, 2019 and 2018 were ~~approximately~~ $0.4 million and $0.7 million, respectively. The decrease was primarily due to a decrease in volume of trucks sold partially offset by improved pricing in 2019.

Cost of Sales

Cost of sales for the three months ended ~~June~~September 30, 2019 and 2018 were ~~$0.9~~$1.4 million and ~~$1.7~~$1.5 million, respectively. The cost of sales decrease was primarily due to ~~the decrease in volume of trucks sold~~lower employee-related costs due to ~~strategic shift to the development of the N-GEN platform. Cost of sales included~~ a ~~$0.8 million charge for excess and obsolete inventory for the period ended June 30, 2019.~~

reduction in headcount.

Cost of sales for the ~~six~~nine months ended ~~June~~September 30, 2019 and 2018 were ~~$2.3~~$3.8 million and ~~$3.4~~$4.8 million, respectively. The cost of sales decrease was primarily due to a decrease in volume of trucks sold due to strategic shift to the development of the N-GEN platform.

Selling, General and Administrative Expenses

Selling, general and administrative (“SG&A”) expenses during the three months ended ~~June~~September 30, 2019 and 2018 were ~~$2.0~~$2.6 million and ~~$3.0~~$3.4 million, respectively. The decrease is primarily due to lower spending for marketing and employee-related costs.

SG&A expenses during the ~~six~~nine months ended ~~June~~September 30, 2019 and 2018 were ~~$4.1~~$6.6 million and ~~$5.4~~$8.8 million, respectively. The decrease related primarily to lower spending in areas such as marketing and employee-related ~~costs partially offset by an increase in stock compensation expense of approximately $0.4 million.~~

costs.

Research and Development Expenses

Research and development (“R&D”) expenses during the three months ended ~~June~~September 30, 2019 and 2018 were ~~$1.2~~$1.6 million and ~~$1.9~~$1.4 million, respectively. The ~~decrease~~increase in R&D expenses is due to ~~the decrease in product design and employee related costs for the USPS NGDV and SureFly.~~

increased spending on prototype development partially offset by lower consulting costs.

R&D expenses during the ~~six~~nine months ended ~~June~~September 30, 2019 and 2018 were ~~$2.6~~$4.2 million and ~~$4.2~~$5.7 million, respectively. The decrease in R&D expenses is due to the decrease in prototype and product design expenses for ~~the USPS NGDV~~our bid for a governmental contract and SureFly.

Interest Expense, Net

Interest expense, net for the three months ended ~~June~~September 30, 2019 and 2018 was ~~$32.7~~$5.9 million and ~~$0.5~~$(0.8) million, respectively. The increase was primarily attributable a ~~$31.1~~$4.0 million mark-to-market adjustment ofin 2019 and a $1.5 million negative mark-to-market adjustment in 2018 for warrants issued to ~~lenders in connection with our financings as well as the~~lenders. In addition there were higher levels of ~~debt.~~

debt year-over-year.

Interest expense, net for the ~~six~~nine months ended ~~June~~September 30, 2019 and 2018 was ~~$34.5~~$23.6 million and ~~$1.1~~$0.3 million, respectively. The increase was primarily attributable ~~the impact of~~ a ~~$31.7~~$19.1 million mark-to-market adjustment ofin 2019 and a $1.5 million negative mark-to-market adjustment in 2018 for warrants issued to ~~lenders in connection with our financings as well as the~~lenders. In addition there were higher levels of ~~debt.~~

debt year-over-year.

Liquidity and Capital Resources

Cash Requirements

From inception, we have financed our operations primarily through sales of equity securities and borrowings. We have consumed substantial amounts of capital to date as we continue our R&D activities and manufacturing our vehicles.

As of ~~June~~September 30, 2019, we had approximately ~~$23.5~~$9.3 million in cash and cash equivalents, as compared to approximately $1.5 million as of December 31, 2018, an increase of ~~$22.0~~$7.7 million. The increase was primarily attributable to the $25.0 million sale of Series B Preferred stock, the amount drawn on the Marathon Tranche Two debt and sales of our common stock. These cash inflows were partially offset by the operating loss for the period.

We believe our existing capital resources ($~~23.5~~9.3 million of cash and cash equivalents at ~~June~~September 30, 2019) and our Marathon revolving credit ~~loans~~facility will be sufficient to support our current and projected funding requirements through the end of 2019. We have based this estimate on assumptions that may prove to be wrong, and we could utilize our available capital resources sooner than we currently expect. Because of the numerous risks and uncertainties associated with the development of our business and research and development activities, including risks and uncertainties that could impact the rate of progress of our development activities, we are unable to estimate with certainty the amounts of increased capital outlays and operating expenditures.

Our operations will require additional funding for the foreseeable future. Unless and until we are able to generate a sufficient amount of revenue and reduce our costs, we expect to finance future cash needs through public and/or private offerings of equity securities, debt financings and/or monetization of existing assets. With the exception of contingent and royalty payments that we may receive under our existing collaborations, we do not currently have any committed future funding. To the extent we raise additional capital by issuing equity securities, our stockholders could at that time experience substantial dilution. Any debt financing we are able to obtain may involve operating covenants that restrict our business.

Our future funding requirements will depend upon many factors, including, but not limited to:

●

~~our ability to acquire or license other technologies or compounds we may seek to pursue;~~

●

~~our ability to manage our growth;~~

●

~~competing technological and market developments;~~

●

~~the costs and timing of obtaining, enforcing and defending our patent and other intellectual property rights; and~~

●

~~expenses associated with any unforeseen litigation.~~

•our ability to acquire or license other technologies or compounds we may seek to pursue;

•our ability to manage our growth;

•competing technological and market developments;

•the costs and timing of obtaining, enforcing and defending our patent and other intellectual property rights; and

•expenses associated with any unforeseen litigation.

Insufficient funds have required and may continue to cause us to delay, scale back or eliminate some or all of our research or development programs, limit our sales activities, limit or cease production or negatively impact our operations.

For the ~~six~~nine months ended ~~June~~September 30, 2019, we maintained an investment portfolio primarily in money market funds. Cash in excess of immediate requirements is invested with regard to liquidity and capital preservation. Wherever possible, we seek to minimize the potential effects of concentration and degrees of risk. We will continue to monitor the impact of the changes in the conditions of the credit and financial markets to our investment portfolio and assess if future changes in our investment strategy are necessary

Summary of Cash Flows

Six Months Ended
June 30,
2019 2018

Net cash used by operating activities $ (11,810,257 ) $ (7,577,673 )
Net cash used by investing activities $ (2,965,372 ) $ -
Net cash provided by financing activities $ 36,782,375 $ 4,094,637

Nine Months Ended September 30,
2019 2018
Net cash used in operating activities $ (24,137,136) $ (17,325,894)
Net cash used in investing activities $ (3,996,838) $ (126,518)
Net cash provided by financing activities $ 36,782,375 $ 16,377,303

Cash Flows from Operating Activities

Our cash flows from operating activities are affected by our cash investments to support ~~the~~our business in research and development, manufacturing, selling, general and administration and interest expense. Our operating cash flows are also affected by our working capital needs to support fluctuations in inventory, personnel expenses, accounts payable and other current assets and liabilities.

During the ~~six~~nine months ended ~~June~~September 30, 2019 and 2018, cash used byin operating activities was ~~$11.8~~$24.1 million and ~~$7.6~~$17.3 million, respectively. The increase in net cash used in operations in 2019 as compared to 2018 was mainly due to changes in ~~accounts receivable,~~prepaid expenses and deposits, accounts payable and accrued liabilities.

Cash Flows from Investing Activities

During the ~~six~~nine months ended ~~June~~September 30, 2019 and 2018, net cash used in investing activities was ~~$3.0~~$4.0 million and ~~zero,~~$0.1 million, respectively. The increase in cash flows used in investing activities in 2019 was primarily driven by investing in tooling for new ~~products.~~

products in 2019.

Cash Flows from Financing Activities

During the ~~six~~nine months ended ~~June~~September 30, 2019 and 2018, net cash provided by financing activities was $36.8 million and ~~$4.1~~$16.4 million, respectively.

The ~~increase in cash flows from~~following significant financing activities ~~was primarily driven by the $25.0 million of proceeds from the sale~~took place in 2019 and 2018:

2019

•Sale of Series B Preferred Stock ~~the $5.8~~with $25.0 million of proceeds

•$5.8 million drawn on the Marathon Tranche Two ~~debt and $5.9~~loan

•$5.9 million of proceeds received from the sale of common ~~stock.~~

stock

2018

•$16.3 million of proceeds received from the sale of common stock

The Company may seek to raise additional capital through public or private debt or equity financings in order to fund its operations.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Critical Accounting Policies

Our accounting policies are fundamental to understanding management’s discussion and analysis of financial condition and results of operations. Our Unaudited Condensed Consolidated Financial Statements are prepared in conformity with GAAP and follow general practices within the industry in which we operate. The preparation of the financial statements requires management to make certain judgments and assumptions in determining accounting estimates. Accounting estimates are considered critical if the estimate requires management to make assumptions about matters that were highly uncertain at the time the accounting estimate was made, and different estimates reasonably could have been used in the current period, or changes in the accounting estimate are reasonably likely to occur from period to period, that would have a material impact on the presentation of our financial condition, changes in financial condition or results of operations.

For a discussion of our critical accounting policies and estimates, see “Critical Accounting Policies” included in our Annual Report onForm 10-K for the year ended December 31, 2018, under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” We have made no significant changes to our critical accounting policies and estimates from those described in our Annual Report onForm 10-K for the year ended December 31, 2018, except as follows:

Warrant Liability

We account for certain common stock warrants that are outstanding as a liability at fair value which is marked to market at the end of each reporting period. The liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire and any change in fair value is recognized as an adjustment to current period interest expense. The fair value of the warrants is measured using a ~~Black Scholes~~Black-Scholes model which includes various inputs, including the market price of our common stock on the balance sheet date and estimated volatility of our common stock. Any significant change in the market price of our common stock may significantly change the value of the liability and impact our results of operations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For a discussion of our quantitative and qualitative disclosures about market risk, see “Quantitative and Qualitative Disclosures About Market Risks” included in our Annual Report onForm 10-K for the year ended December 31, 2018, under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” There have been no material changes to the information provided in our Annual Report onForm 10-K for the year ended December 31, 2018.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Pursuant to Rules 13a-15(b) and 15-d-15(b) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer of the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this report. The term “disclosure controls and procedures”, as defined under Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were not effective due to material weaknesses in our internal control over financial reporting that existed as of ~~June~~September 30, 2019, as discussed below.

As previously disclosed in our Annual Report onForm 10-K for the year ended December 31, 2018, we identified the following material weaknesses:

●

~~The Company has not established adequate financial reporting monitoring activities to mitigate the risk of accounting errors~~

●

~~The lack of a fully implemented enterprise resource planning (“ERP”) system caused over reliance on manual entries.~~

•The Company has not established adequate financial reporting monitoring activities to mitigate the risk of accounting errors

•The lack of a fully implemented enterprise resource planning (“ERP”) system caused over reliance on manual entries.

With respect to our internal control over financial reporting, these material weaknesses have been and continue to be discussed among management and our Audit Committee. Management ~~intends to review, revise~~has moved forward and ~~improve~~is revising and improving our internal control over financial reporting until the material weaknesses in internal control over financial reporting are remediated.

Management’s specific remediation to address these material weaknesses will and has included among other items:

●

~~Complete implementation of the ERP system modules covering purchase orders and inventory.~~

●

Hire an international accounting firm to assist the company with a broad-based review of our internal control environment including the identification of controls gaps and implementation of controls to remediate those gaps.

•Complete implementation of the ERP system modules covering purchase orders and inventory.

•Hire an international accounting firm to assist the company to perform a broad-based review of our internal control environment including the identification of controls gaps and implementation of controls to remediate those gaps.

•Adding additional resources to strengthen our accounting and finance function

As of September 30, 2019, the Company has substantially completed its review of the design of internal controls and is in process of implementing enhancements to its internal controls over financial reporting to address any gaps identified during the review of design. In addition, the Company has evaluated the design and operation of control activities and procedures associated with user and administrator access to our Information Technology (“IT”) systems, including removing all inappropriate IT system access associated with information technology general controls ("ITGCs"). We have evaluated and improved change management and computer operation control activities that contributed to the material weakness.

We believe the ~~initiated~~ remediation measures described above will strengthen our internal control over financial reporting and should eventually remediate the material weaknesses identified. However, because we are still assessing the design and operating effectiveness of these measures and need to put more controls in place, the identified material weaknesses have not been remediated as of ~~June~~September 30, 2019. We will continue to monitor the effectiveness of these remediation measures and will make any changes and take such other actions that we deem appropriate.

We assessed the material weaknesses’ impact to the condensed consolidated financial statements to ensure they were prepared in accordance with GAAP and present fairly the condensed consolidated financial position, financial results of operations and cash flows as of and for the three months ended ~~June~~September 30, 2019. Based on these additional procedures and assessment, we concluded that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material aspects, our financial position, results of operations and cash flows for the periods presented.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as that term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended ~~June~~September 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are involved from time to time in legal proceedings incidental to the conduct of our business. We do not believe that any liability that may result from these proceedings will have a material adverse effect on our Unaudited Condensed Consolidated Financial Statements. On July 18, 2019, All Cell Technologies, LLC and Illinois Institute of Technology filed a Complaint for Patent Infringement against the Company in the United States District Court for the Southern District of ~~Indiana.~~Indiana (Civil Action No. 1:19-cv-2975) claiming infringement of US Patent No. 6,468,689, 6.942,944 and, 8,273,474. On October 28, 2019, the Company filed its Answer, Affirmative Defenses and Counterclaims. Management of the Company believes this lawsuit is baseless and intends to defend itself vigorously.

ITEM 1A. RISK FACTORS

For a detailed discussion of risk factors affecting us, see “Part I – Item 1A. Risk Factors” in our Annual Report onForm 10-K for the year ended December 31, 2018.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

February 2019 Private Placement

Commencing February 11, 2019, the Company entered into and closed Subscription Agreements with accredited investors (the “February 2019 Accredited Investors”) pursuant to which the February 2019 Accredited Investors purchased 1,616,683 shares of the Company’s common stock for a purchase price of $1,465,056. If, prior to the six month anniversary, the Company issues shares of its common stock for a purchase price per share less than the purchase price paid by the February 2019 Accredited Investors subject to standard carve-outs (a “Down Round”), the Company will issue additional shares of common stock (for no additional consideration) to the February 2019 Accredited Investors such that the effective purchase price per share is equal to the purchase price per share paid in the Down Round. Benjamin Samuels and Gerald Budde, directors of the Company, acquired 841,928 and 26,310 shares of common stock, respectively, as part of this offering at a per share purchase was $0.9501, which was above the closing price the date prior to close. They did not receive the Down Round protection.

Series B Preferred Stock Placement

Commencing May 31, 2019 through June 5, 2019, the Company entered into Subscription Agreements with institutional investors pursuant to which the investors for an aggregate purchase price of $25,000,000 purchased 1,250,000 units consisting of (i) one newly-issued share of Series B Preferred Stock, with a stated value of $20.00 per share (the “Stated Value”) and a par value of $0.001 per share (the “Preferred Stock”), and (ii) a common stock purchase warrant to purchase 7.41 shares of the common stock, par value $0.001 per share, of the Company. (the “Warrants”). The closing with respect to approximately $15,000,000 occurred on May 31, 2019 and the balance of approximately $10,000,000 will close on June 10, 2019.

The rights, preferences, privileges and limitations of the Preferred Stock are set forth in a certificate of designation filed by the Company with the Secretary of State of the State of Nevada (the “Certificate of Designation”). The Preferred Stock ranks senior to the Company’s common stock with respect to dividend rights and rights upon liquidation, winding-up or dissolution. The Preferred Stock is entitled to annual dividends at a rate equal to 8.0% simple interest per annum on the Stated Value of the Preferred Stock. Accrued dividends will be payable quarterly in shares of common stock of the Company based on a share price of $1.62, which was the average closing price of the Company’s common stock on the five trading days immediately preceding May 31, 2019 and in excess of the closing price of $1.60 on May 30, 2019.

The Preferred Stock is not convertible and does not hold voting rights. Upon any liquidation, dissolution or winding up of the Company, liquidation of the Company’s assets will be made in the following order of priority: (a) first, payment or provision for payment of debts and other liabilities; (b) second, payment to the holders of the Preferred Stock an amount with respect to each share of the Preferred Stock’s Stated Value plus any accrued but unpaid dividends thereon; and (c) third, payment to the holders of common stock.

On the fourth anniversary of the Closing Date, the Company shall redeem all the outstanding shares of the Preferred Stock at the Stated Value, plus accrued and unpaid dividends. At any time prior to such date, the Company subject to the repayment and retirement, in accordance with its terms, of the Credit Agreement dated as of December 31, 2018 (the “Credit Agreement”), among the Company, as the borrower, the lenders thereto and Wilmington Trust, National Association, as Agent, the Company may, in its sole discretion, redeem any outstanding shares of Preferred Stock at the Stated Value, plus accrued and unpaid

dividends (“Optional Redemption”). Notwithstanding the foregoing, the Company may effect an Optional Redemption prior to the fourth anniversary of the Closing Date so long as it obtains from the lenders to the Credit Agreement their prior written consent to such Optional Redemption.

The Warrants have an exercise price of $1.62 per share, which was in excess of the closing price of $1.60 on May 30, 2019, are immediately exercisable and will expire seven years from the date of issuance.

Notwithstanding anything herein to the contrary, the aggregate number of shares of common stock issued in payment of dividends on the Preferred Stock when added to the number of shares of common stock issued upon exercise of any warrants shall not exceed 19.9% of either (a) the total number of shares of common stock outstanding on the date hereof or (b) the total voting power of the Company’s securities outstanding on the date hereof that are entitled to vote on a matter being voted on by holders of the common stock, unless and until the Company obtains stockholder approval permitting such issuances in accordance with applicable rules of the NASDAQ Capital Market.

The offer, sale and issuance of the above securities was made to accredited investors and the Company relied upon the exemptions contained in Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D promulgated thereunder with regard to the sale. No advertising or general solicitation was employed in offering the securities. The offer and sales were made to accredited investors and transfer of the common stock will be restricted by the Company in accordance with the requirements of the Securities Act of 1933, as amended.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

~~None~~

None.

ITEM 6. EXHIBITS

~~Exhibit No.~~	~~Description~~
~~31.1~~Exhibit No.		Description
31.1*		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
~~31.2~~31.2*		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
~~32.1~~32.1*		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
~~32.2~~32.2*		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
~~EX-101.INS~~101.INS		Inline XBRL INSTANCE DOCUMENT
~~EX-101.SCH~~101.SCH		Inline XBRL ~~TAXONOMY EXTENSION SCHEMA DOCUMENT~~Taxonomy Extension Schema Document
~~EX-101.CAL~~101.CAL		Inline XBRL ~~TAXONOMY EXTENSION CALCULATION LINKBASE~~Taxonomy Extension Calculation Linkbase Document
~~EX-101.DEF~~101.DEF		Inline XBRL ~~TAXONOMY EXTENSION DEFINITION LINKBASE~~Taxonomy Extension Definition Linkbase Document
~~EX-101.LAB~~101.LAB		Inline XBRL ~~TAXONOMY EXTENSION LABELS LINKBASE~~Taxonomy Extension Labels Linkbase Document
~~EX-101.PRE~~101.PRE		Inline XBRL ~~TAXONOMY EXTENSION PRESENTATION LINKBASE~~Taxonomy Extension Presentation Linkbase Document
104		Inline XBRL Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	~~Filed herewith.~~

*Filed herewith.

SIGNATURES

Pursuant to the requirements of ~~Section 13 or 15(d) of~~ the Securities ~~and~~ Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned ~~hereunto~~thereunto duly authorized.


		WORKHORSE GROUP INC.

Dated: ~~August 9,~~November 8, 2019		By:	/s/ Duane A. Hughes
			Name: Duane A. Hughes
	Title: Chief Executive Officer (Principal Executive Officer)


Dated: ~~August 9,~~November 8, 2019		By:	/s/ Paul Gaitan
			Name: Paul Gaitan
	Title: Chief Financial Officer
	(Principal Financial and Accounting Officer)

~~Nevada~~	~~26-1394771~~
Nevada		26-1394771
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)


Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐


Common Stock, $0.001 par value per share						~~66,186,447~~66,857,529
(Class)						(Outstanding at ~~July~~October 31, 2019)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	June 30, 2019			December 31, 2018
Assets

Current assets:
Cash and cash equivalents	$	23,519,496		$	1,512,750
Lease receivable		42,244			48,271
Inventory		2,197,683			2,533,616
Prepaid expenses and deposits		1,720,319			2,274,595
		27,479,742			6,369,232

Noncurrent assets:
Property, plant and equipment, net of accumulated depreciation of $2,601,263 and $2,407,477 at June 30, 2019 and December 31, 2018		8,009,037			5,237,451
Lease receivable		179,982			198,090
	$	35,668,761		$	11,804,773

Liabilities and Stockholders’ Equity (Deficit)

Current liabilities:
Accounts payable	$	2,010,334		$	4,340,463
Accrued liabilities		4,047,550			3,946,386
Warranty liability		6,573,560			7,058,769
Warrant liability		33,529,599			1,822,819
Customer deposits		359,000			406,000
Duke financing obligation		1,340,700			1,340,700
Revolving loan		5,854,140			-
		53,714,883			18,915,137

Long-term debt		8,572,182			8,312,079
Mandatory redeemable series B preferred stock		18,409,510			-
Commitments and Contingencies
Stockholders’ equity (deficit):
Series A preferred stock, par value of $.001 per share 75,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2019 and December 31, 2018		-			-
Common stock, par value of $.001 per share 250,000,000 shares authorized, 66,081,812 shares issued and outstanding at June 30, 2019 and 58,270,934 shares issued and outstanding at December 31, 2018		66,082			58,271
Additional paid-in capital		139,670,292			126,076,782
Accumulated deficit		(184,764,188	)		(141,557,496	)
		(45,027,814	)		(15,422,443	)
	$	35,668,761		$	11,804,773

	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018

Net sales	$	5,508		$	170,684		$	369,690		$	730,913
Cost of sales		930,164			1,655,905			2,327,770			3,370,275
Gross loss		(924,656	)		(1,485,221	)		(1,958,080	)		(2,639,362	)

Operating expenses
Selling, general and administrative		1,996,054			3,003,202			4,086,944			5,403,349
Research and development		1,216,727			1,894,712			2,579,002			4,232,343
Total operating expenses		3,212,781			4,897,914			6,665,946			9,635,692

Interest expense, net		32,718,876			526,162			34,496,459			1,052,049

Net loss		(36,856,313	)		(6,909,297	)		(43,120,485	)		(13,327,103	)

Deemed dividends		86,207			765,179			86,207			765,179

Net loss attributable to common stockholders	$	(36,942,520	)	$	(7,674,476	)	$	(43,206,692	)	$	(14,092,282	)

Net loss attributable to common stockholders per share - basic and diluted	$	(0.61	)	$	(0.18	)	$	(0.71	)	$	(0.33	)

Weighted average number of common shares outstanding		60,530,168			42,406,471			60,530,168			42,406,471

	Common Stock				Series A Preferred Stock				Additional						Total Stockholders’
	Number of Shares		Amount		Number of Shares		Amount		Paid-in Capital			Accumulated Deficit			Equity (Deficit)
Balance, March 31, 2018		41,966,550	$	41,966	$	-	$	-	$	109,106,507		$	(110,707,807	)	$	(1,559,334	)
Issuance of common stock		3,034,169		1,065		-		-		2,832,861			-			2,833,926
Stock options and warrants exercised		2,500		3		-		-		2,748			-			2,751
Warrant exchange		-		1,969		-		-		(1,969	)		-			-
Deemed dividend, Sept 17 warrants		-		-		-		-		765,179			(765,179	)		-
Share based compensation		-		-		-		-		476,085			-			476,085
Net loss		-		-		-		-		-			(6,909,297	)		(6,909,297	)
Balance, June 30, 2018		45,003,219	$	45,003	$	-	$	-	$	113,181,411		$	(118,382,283	)	$	(5,155,869	)

	2019		2018
Raw materials	$	4,285,830	$	4,319,637
Work in process		422,176		702,079
Finished goods		-		-
		4,708,006		5,021,716
Less: Inventory reserve		2,510,323		2,488,100
	$	2,197,683	$	2,533,616


	Three Months Ended September 30,						Nine Months Ended September 30,
	2019		2018		2019		2018
Net loss	$	(11,493,587)	$	(5,485,553)	$	(37,817,959)	$	(18,812,656)
Deemed dividends	—		—		86,207		765,179
Net loss attributable to common shareholders	$	(11,493,587)	$	(5,485,553)	$	(37,904,166)	$	(19,577,835)

Basic weighted average shares outstanding	66,176,921		46,192,471		63,566,295		46,192,471
Dilutive effect of options and warrants	—		—		—		—
Diluted weighted average shares outstanding	66,176,921		46,192,471		63,566,295		46,192,471

Anti-dilutive options and warrants excluded from diluted average shares outstanding	32,917,619		4,558,927		32,917,619		4,558,927


	Three Months Ended September 30,						Nine Months Ended September 30,
	2019		2018		2019		2018
Net sales	$	4,258	$	10,997	$	373,948	$	741,910
Cost of sales	1,423,904		1,476,822		3,751,674		4,847,097
Gross loss	(1,419,646)		(1,465,825)		(3,377,726)		(4,105,187)

Operating expenses:
Selling, general and administrative	2,551,406		3,363,103		6,638,350		8,766,452
Research and development	1,640,454		1,449,497		4,219,456		5,681,840
Total operating expenses	4,191,860		4,812,600		10,857,806		14,448,292

Loss from operations	(5,611,506)		(6,278,425)		(14,235,532)		(18,553,479)

Interest expense, net	5,882,081		(792,872)		23,582,427		259,177

Net loss	$	(11,493,587)	$	(5,485,553)	$	(37,817,959)	$	(18,812,656)